REGENXBIO Inc (RGNX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Kenneth T. Mills
Employees:
192
9600 BLACKWELL ROAD, SUITE 210, ROCKVILLE, MD 20850
240-552-8181

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Data derived from most recent annual or quarterly report
Market Cap 1.046 Billion Shares Outstanding43.134 Million Avg 30-day Volume 498.645 Thousand
P/E Ratio21.7498 Dividend Yield0.0 EPS
Price to Revenue3.0012 Debt to Equity0.0 EBITDA149.454 Million
Price to Book Value2.0758 Operating Margin27.775899999999996 Enterprise Value666.822 Million
Current Ratio3.726 EPS Growth1.748 Quick Ratio3.512
1 Yr BETA 1.4937 52-week High/Low 46.46 / 18.69 Profit Margin21.227
Operating Cash Flow Growth431.0322 Altman Z-Score3.5104 Free Cash Flow to Firm 90.899 Million
Earnings Report2022-08-09
View SEC Filings from RGNX instead.

View recent insider trading info

Funds Holding RGNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RGNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-25:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2022-03-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-14:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-09:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-15:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2021-11-12:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-09:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MIGAUSKY GEORGE V

    18,334 2022-06-03 3

    KARABELAS ARGERIS N

    18,334 2022-06-03 1

    STUMP DAVID C

    18,334 2022-06-03 1

    TASSE DANIEL

    18,334 2022-06-03 1

    FOX ALLAN M.

    18,334 2022-06-03 3

    GLUCKSMANN ALEXANDRA

    18,334 2022-06-03 1

    ZACHARY JENNIFER

    0 2022-06-03 2

    BENNETT JEAN

    18,334 2022-06-03 3

    VASISTA VITTAL CHIEF FINANCIAL OFFICER

    197,440 2022-01-20 3

    SIMPSON CURRAN CHIEF OPER. & TECH. OFFICER

    78,216 2022-01-01 1

    CHRISTMAS PATRICK J. CHIEF LEGAL OFFICER

    60,340 2022-01-01 1

    MILLS KENNETH T. PRESIDENT AND CEO

    480,032 2022-01-01 5

    PAKOLA STEVE CHIEF MEDICAL OFFICER

    59,650 2022-01-01 1

    DANOS OLIVIER CHIEF SCIENTIFIC OFFICER

    80,178 2022-01-01 1

    BESHAR LUKE M

    10,000 2021-06-04 0

    ABDUN-NABI DANIEL

    10,000 2021-06-04 0

    HAYDEN DONALD J JR

    0 2020-05-29 0

    YOO STEPHEN CHIEF MEDICAL OFFICER

    0 2018-12-03 0

    ALI FARAZ CHIEF BUSINESS OFFICER

    • Officer
    0 2017-01-04 0

    SAMUELS CAMILLE D

    • Director
    0 2016-06-01 0

    FMR LLC

    • SEE REMARK 1
    No longer subject to file 2016-05-17 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT CO

    DEERFIELD MGMT III, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD INTERNATIONAL MASTER FUND, L.P.

    DEERFIELD PARTNERS, LP

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    No longer subject to file 2015-09-22 0

    ENGLEMAN EDGAR

    • Director
    940,449 2015-09-22 0

    FLYNN JAMES E

    DEERFIELD MGMT III, L.P.

    DEERFIELD MANAGEMENT CO

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    0 2015-09-16 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BENNETT JEAN

    2022-06-07 16:16:06 -0400 2022-06-03 A 3,010 a 3,010 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    BENNETT JEAN

    2022-06-07 16:16:06 -0400 2022-06-03 A 15,324 a 15,324 direct

    GLUCKSMANN ALEXANDRA

    2022-06-07 16:18:08 -0400 2022-06-03 A 3,010 a 3,010 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    GLUCKSMANN ALEXANDRA

    2022-06-07 16:18:08 -0400 2022-06-03 A 15,324 a 15,324 direct

    FOX ALLAN M.

    2022-06-07 16:17:14 -0400 2022-06-03 A 3,010 a 3,010 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    FOX ALLAN M.

    2022-06-07 16:17:14 -0400 2022-06-03 A 15,324 a 15,324 direct

    MIGAUSKY GEORGE V

    2022-06-07 16:21:01 -0400 2022-06-03 A 3,010 a 3,010 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    MIGAUSKY GEORGE V

    2022-06-07 16:21:01 -0400 2022-06-03 A 15,324 a 15,324 direct

    KARABELAS ARGERIS N

    2022-06-07 16:20:05 -0400 2022-06-03 A 3,010 a 3,010 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    KARABELAS ARGERIS N

    2022-06-07 16:20:05 -0400 2022-06-03 A 15,324 a 15,324 direct

    TASSE DANIEL

    2022-06-07 16:23:27 -0400 2022-06-03 A 3,010 a 3,010 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    TASSE DANIEL

    2022-06-07 16:23:27 -0400 2022-06-03 A 15,324 a 15,324 direct

    STUMP DAVID C

    2022-06-07 16:22:20 -0400 2022-06-03 A 3,010 a 3,010 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    STUMP DAVID C

    2022-06-07 16:22:20 -0400 2022-06-03 A 15,324 a 15,324 direct

    ZACHARY JENNIFER

    2022-06-07 16:26:36 -0400 2022-06-03 A 6,020 a 6,020 direct -3.7952 -7.5022 0.0 1 -13.1951 4

    ZACHARY JENNIFER

    2022-06-07 16:26:36 -0400 2022-06-03 A 29,739 a 29,739 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    REGENXBIO INC RGNX 2022-06-30 22:15:03 UTC 1.1275 0.4425 950000
    REGENXBIO INC RGNX 2022-06-30 21:45:03 UTC 1.1515 0.4185 950000
    REGENXBIO INC RGNX 2022-06-30 21:15:03 UTC 1.1515 0.4185 950000
    REGENXBIO INC RGNX 2022-06-30 20:45:03 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 20:15:04 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 19:45:03 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 19:15:03 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 18:45:04 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 18:15:04 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 17:45:03 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 17:15:03 UTC 1.1168 0.4532 950000
    REGENXBIO INC RGNX 2022-06-30 16:45:04 UTC 1.0912 0.4788 950000
    REGENXBIO INC RGNX 2022-06-30 16:15:03 UTC 1.0912 0.4788 950000
    REGENXBIO INC RGNX 2022-06-30 15:45:03 UTC 1.0912 0.4788 950000
    REGENXBIO INC RGNX 2022-06-30 15:15:03 UTC 1.0912 0.4788 950000
    REGENXBIO INC RGNX 2022-06-30 14:45:03 UTC 1.0912 0.4788 950000
    REGENXBIO INC RGNX 2022-06-30 14:15:03 UTC 1.0912 0.4788 950000
    REGENXBIO INC RGNX 2022-06-30 13:45:03 UTC 1.0949 0.4751 950000
    REGENXBIO INC RGNX 2022-06-30 13:15:03 UTC 1.0949 0.4751 950000
    REGENXBIO INC RGNX 2022-06-30 12:45:03 UTC 1.0949 0.4751 950000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund RGNX -223.0 shares, $-7220.74 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund RGNX -138.0 shares, $-4468.44 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund RGNX -161.0 shares, $-5213.18 2020-03-31 N-PORT
    Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund RGNX -7790.0 shares, $-258550.1 2022-03-31 N-PORT

    Elevate your investments